163.52MMarket Cap-13.59P/E (TTM)
26.9100High24.0000Low104.22KVolume24.6300Open24.9800Pre Close2.67MTurnover2.66%Turnover RatioLossP/E (Static)6.08MShares38.500052wk High33.06P/B105.40MFloat Cap1.545052wk Low--Dividend TTM3.92MShs Float240.0000Historical High--Div YieldTTM11.65%Amplitude1.3695Historical Low25.5770Avg Price1Lot Size
Monopar Therapeutics Stock Forum
Monopar Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CHANDLER ROBINSON(19.2%),MICHAEL BROWN(17.1%), etc.
Cash and Net Loss
Cash and cash equivalents as of September 30, 2024, were $6.0 million. As noted above, the Company completed a registered public offering on October 30, 2024 that yielded net proceeds to the Company of approximately $17.7 million, after deducting placement agent fees and other estimated offering expenses.
Monopar project...
can anyone tell me which stock should I buy to get profit because the onse I've been had they're only giving return of 4 to 5%
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
are also boosting portfolios….
and
and
and
are also doing ok (beyond the obvious $Tesla (TSLA.US)$ , $NVIDIA (NVDA.US)$ and $MicroStrategy (MSTR.US)$ .
No comment yet